<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Phosphatidic acid (PA) increases Psoriasis — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Phosphatidic acid (PA)</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>Psoriasis</strong>
</div>
<div class="entity-id">HMDB:HMDB0062447 &nbsp;&middot;&nbsp; MESH:D011565</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 46.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 7 citations: <strong>46.00</strong><br><span style="color:#888">3&times; extends (+36.00) &middot; 2&times; supports (+20.00) &middot; 2&times; contradicts (-10.00)</span><br>Neighbourhood: 49.59</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1093/gigascience/gix087">10.1093/gigascience/gix087</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS408">MTBLS408</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 7 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:67px"></span><span>2</span><span class="cite-subtotal">&middot; +20.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidic acid (LPA) — is_biomarker_for → Psoriasis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/567eaedbddd0c1c8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Glycerophospholipid metabolism — correlates_with → Psoriasis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/7959461355e976a2.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:67px"></span><span>2</span><span class="cite-subtotal">&middot; -10.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Phosphatidylcholine (PC) — decreases → Psoriasis</span><span class="cite-claim-weight">-5.00</span><a href="../claim/e5e90139bb48f28f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Phosphatidylinositol (PI) — decreases → Psoriasis</span><span class="cite-claim-weight">-5.00</span><a href="../claim/8f33fc24536d24e4.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>3</span><span class="cite-subtotal">&middot; +36.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidic acid (LPA) — increases → Psoriasis</span><span class="cite-claim-weight">+12.00</span><a href="../claim/ecd2aa839b76d2f2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — increases → Psoriasis</span><span class="cite-claim-weight">+12.00</span><a href="../claim/8ae80e0e48ab27cf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Psoriasis</span><span class="cite-claim-weight">+12.00</span><a href="../claim/00268f974bb50858.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>f9ae007136ec723f</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0062447">HMDB:HMDB0062447</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D011565">MESH:D011565</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
